GN executive: ”We fear neither Trump nor Brexit”

A forthcoming Brexit, extra taxes on medical devices, OTC markets, and an unruly Donald Trump – it all creates political and regulatory uncertainty. However, it does not discourage CEO in GN Hearing, Anders Hedegaard. “We are well placed to deliver,” he says.

Photo: GN Resound, PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles